Abdominal aortic aneurysms and diabetes mellitus

J Diabetes Complications. 2015 Nov-Dec;29(8):1330-6. doi: 10.1016/j.jdiacomp.2015.08.011. Epub 2015 Aug 20.

Abstract

There is accumulating evidence that risk profiles differ between coronary artery disease and abdominal aortic aneurysms (AAAs). However, diabetes mellitus (DM) appears to be negatively associated with AAA formation. The underlying mechanisms for this negative relationship are far from defined, but may include: increased arterial wall matrix formation via advanced glycation end products; suppression of plasmin and reduction of levels and activity of matrix metalloproteinases (MMP)-2 and 9; diminished aortic wall macrophage infiltration, elastolysis and neovascularization. In addition, the effect of pharmacological agents used for the treatment of patients with DM on AAA formation has been studied with rather controversial results. Statins, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, fenofibrate, antibiotics and some hypoglycemic agents are beginning to be appreciated for a potential modest protection from AAAs, but further studies are needed.

Keywords: Aorta; Aortic aneurysm; Atherosclerosis; Diabetes mellitus; Pathogenesis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Aortic Aneurysm, Abdominal / epidemiology*
  • Aortic Aneurysm, Abdominal / physiopathology
  • Aortic Aneurysm, Abdominal / prevention & control
  • Atherosclerosis / epidemiology
  • Atherosclerosis / physiopathology
  • Diabetic Angiopathies / epidemiology*
  • Diabetic Angiopathies / physiopathology
  • Diabetic Angiopathies / prevention & control
  • Disease Resistance / drug effects
  • Evidence-Based Medicine*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Risk Factors

Substances

  • Anti-Bacterial Agents
  • Hypoglycemic Agents